Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Leflunomide and anthralin may effectively treat severe alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

A mutation in the IL2RA gene increases the risk of alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

The combination therapy was effective and well-tolerated, especially in young patients.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Abatacept may help some people with alopecia areata regrow hair.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.